ConductScience.org, home

Paper8943097

Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.

Vrionis FD and 4 others. J Neurooncol, 1996. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells. Papers, record 8943097. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8943097

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.
PubMed
Journal
J Neurooncol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.19
iCite
Revised in PubMed
2019-09-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vrionis FDF D
2Wu JKJ K
3Qi PP
4Cano WGW G
5Cherington VV

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarcinosarcomaMajor topic
Genetic TherapyMajor topic
SimplexvirusMajor topic
Thymidine KinaseMajor topic
Animals
Antiviral Agents
Blotting, Western
Cell Survival
Cell Transformation, Viral
Ganciclovir
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Viral
Injections, Spinal
Plasmids
Rats
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30DK 34928NIDDK NIH HHSUnited StatesP30DK034928PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13019523Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.Cancer Res1986https://conductscience.org/library/papers/3019523PubMed
28380127In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.Cancer Res1993https://conductscience.org/library/papers/8380127PubMed
38221662The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.Cancer Res1993https://conductscience.org/library/papers/8221662PubMed
43685260Computer programs for the analysis of cellular survival data.Radiat Res1987https://conductscience.org/library/papers/3685260PubMed
58384892Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir.Hum Gene Ther1993https://conductscience.org/library/papers/8384892PubMed
61423266Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.Cancer Res1992https://conductscience.org/library/papers/1423266PubMed
78391069An experimental model of retrovirus gene therapy for malignant brain tumors.J Neurosurg1993https://conductscience.org/library/papers/8391069PubMed
81317968In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.Science1992https://conductscience.org/library/papers/1317968PubMed
91450408Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.Blood1992https://conductscience.org/library/papers/1450408PubMed
108186287In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy.Hum Gene Ther1993https://conductscience.org/library/papers/8186287PubMed
111335754Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines.J Immunother (1991)1992https://conductscience.org/library/papers/1335754PubMed
126315212Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases.Cancer1983https://conductscience.org/library/papers/6315212PubMed
138346212Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8346212PubMed
142833027Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity.Virology1988https://conductscience.org/library/papers/2833027PubMed
158592228Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats.J Neurosurg1996https://conductscience.org/library/papers/8592228PubMed
168058777Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8058777PubMed
171851332Experimental therapy of human glioma by means of a genetically engineered virus mutant.Science1991https://conductscience.org/library/papers/1851332PubMed
187954393Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene.Cancer Res1994https://conductscience.org/library/papers/7954393PubMed
197923150Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.Cancer Res1994https://conductscience.org/library/papers/7923150PubMed
208183911Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8183911PubMed

See all 25 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
11110418Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.Gene Ther2000https://conductscience.org/library/papers/11110418PubMed
9696378Gene therapy of neoplastic meningosis.J Neurooncol1998https://conductscience.org/library/papers/9696378PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8943097

GET https://conductscience.org/api/papers/v1/8943097/references?page=2